Read the latest news from Northwestern University Feinberg School of Medicine’s Parkinson's Disease and Movement Disorders Center. The links below take you to articles where you can learn more about our faculty’s latest achievements, awards, and honors.
- 09.13.2017Northwestern Medicine scientists have identified a toxic cascade that leads to neuronal degeneration in patients with Parkinson’s disease (PD), findings published in the journal Science.
- 06.21.2015A multidisciplinary Huntington’s Disease clinic, part of the Parkinson’s Disease and Movement Disorders Center at Feinberg, launched this spring to be that one-stop shop, a place where patients can receive comprehensive care to manage their symptoms and improve their quality of life.
- 05.03.2014Center study featured in the Chicago Sun Times for May 3, 2014.
- 04.02.2014Tanya Simuni, MD, medical director of Northwestern University’s Parkinson’s Disease and Movement Disorders Center, was awarded a grant from the National Institutes of Health (NIH) to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson’s disease.
Recognized for its approach to uncovering new therapeutic targets in the fight against Parkinson’s disease (PD), Northwestern University Feinberg School of Medicine will continue that pursuit as a National Institutes of Health Center of Excellence. The only medical school to receive new or renewed designation as a Morris K. Udall Center of Excellence for Parkinson’s Disease Research in 2013, Feinberg became the Midwest’s first site in 2003, and today is one of just 10 nationwide.